These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11333708)

  • 1. [Treatment of lipodystrophy in patients with human immunodeficiency virus infection].
    Paredes R; Muñoz J; Díaz I; Domingo P
    Med Clin (Barc); 2001 Mar; 116(12):469-75. PubMed ID: 11333708
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.
    Borderi M; Verucchi G; Tadolini M; Spinosa S; Fortunato L; Talò S; Chiodo F
    New Microbiol; 2001 Jul; 24(3):303-15. PubMed ID: 11497090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Facial lipodystrophy in patients with HIV infections troublesome to treat].
    Walther RA
    Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
    Moyle G; Carr A
    HIV Clin Trials; 2002; 3(1):89-98. PubMed ID: 11894812
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-associated asymmetric lipodystrophy syndrome.
    Quiros-Roldan E; Moretti F; Torti C; Casari S; Prestini K; Carosi G
    Rev Clin Esp; 2004 Mar; 204(3):177. PubMed ID: 15025990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of lipodystrophy: no clear answers to clinical questions].
    Volkert R
    Dtsch Med Wochenschr; 2001 Dec; 126(49):A1118. PubMed ID: 11791516
    [No Abstract]   [Full Text] [Related]  

  • 7. Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy.
    Rodriguez-Guardado A; Maradona JA; Carton JA; Asensi V
    AIDS; 2002 Jul; 16(10):1434-6. PubMed ID: 12131227
    [No Abstract]   [Full Text] [Related]  

  • 8. Update from the 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
    Brown T; Confrancesco J
    Hopkins HIV Rep; 2005 Jan; 17(1):4-5, 8. PubMed ID: 16419320
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.
    Chen D; Misra A; Garg A
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4845-56. PubMed ID: 12414837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch therapy studies.
    Mallon PW
    J HIV Ther; 2001 May; 6(2):45-8. PubMed ID: 11505945
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection.
    Holstein A; Plaschke A; Egberts EH
    Exp Clin Endocrinol Diabetes; 2001; 109(8):389-92. PubMed ID: 11748485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sex and race on lipodystrophy pathogenesis.
    Nolan D; Mallal S
    J HIV Ther; 2001 May; 6(2):32-6. PubMed ID: 11501201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Delayed virus suppression has its price. Heart and liver are no longer secondary theaters].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():12-4. PubMed ID: 12043063
    [No Abstract]   [Full Text] [Related]  

  • 14. Fat, sugar and drugs on the French Riviera.
    Lands L
    GMHC Treat Issues; 1999 Mar; 13(3):9-11. PubMed ID: 11366205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifty fat and bad bones (or, in vivo veritas).
    Mascolini M
    IAPAC Mon; 2000 Nov; 6(11):326-50. PubMed ID: 11299996
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolic disorders and lipodystrophy. Adverse effects of antiretroviral therapy].
    Goebel FD; Westner I
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():40-4. PubMed ID: 11373778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Diego, California, USA 22-25 September 2002.
    Nolan D; Christiansen F
    Expert Opin Drug Saf; 2003 Jan; 2(1):95-101. PubMed ID: 12904128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly active antiretroviral therapy and coronary heart disease: the need for perspective.
    Egger M; Junghans C; Friis-Møller N; Lundgren JD
    AIDS; 2001; 15 Suppl 5():S193-201. PubMed ID: 11816168
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity of antiretroviral therapy and implications for drug development.
    Carr A
    Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.
    Vidal F; Domingo P; Viladés C; Peraire J; Arnedo M; Alcamí J; Leal M; Villarroya F; Gatell JM
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1365-82. PubMed ID: 21999362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.